Novigenix SA
Novigenix is a precision medicine Tech Bio offering state-of-the-art ImmunoTranscriptomic liquid biopsy solutions with unprecedented predictive capabilities for precision development of novel therapeutics. Our AI-enabled ISO-13485 certified RNA analytic platform delivers ImmunoPD biomarkers, insights into mechanism of action and resistance, and early markers for severe toxicity to accelerate clinical development.
Date, time and room information
May 6, 12:30 - 12:45, room Marriott 1+2
Category
Commercial stage company
Title of the presentation
AI-Powered RNA Liquid Biopsy Accelerating Clinical Development of Novel Therapeutics
Speaker information
| Name | Position | Institution |
|---|---|---|
| Brian B. Hashemi | CEO & Chairman | Novigenix SA |
